Latest filing published 02 May 2023 for Oak Street Health, Inc., €17.3M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robert Guenthner is a declared insider of Oak Street Health, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 29 filings, for trades running from 6 May 2021 to 2 May 2023.
The open-market record consists of 24 sales worth €2.9M, with no purchase. Other entries cover 3 share grants and 1 option exercise. In 2023 alone, the filings show no purchases and 6 sales.
Most recently, on 2 May 2023, the filings show a transaction worth €17.3M in Oak Street Health, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations